Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

By Addeo Raffaele   Caraglia Michele   Santi M.   Montella Liliana   Abbruzzese Alberto   Parlato Ciro   Vincenzi Bruno   Carraturo Marco   Faiola Vincenzo   Genovese Michele   Cennamo Gregorio   Prete Salvatore  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 425-425

Springer Publishing Company

Access to resources Recommend Favorite

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

By Gaviani Paola  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 617-618

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

By Santoni Matteo  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 397-401

Springer Publishing Company

Access to resources Recommend Favorite

Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug

By Addeo Raffaele  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 863-866

Springer Publishing Company

Access to resources Recommend Favorite

Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite